Pfizer mulls possible OTC switch for Lipitor

Share this article:

Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor – a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity in November. But the reception from analysts has been muted so far. Pfizer is exploring the possibility of a branded generic, as well as an OTC switch, according to several sources.


Share this article:

More in Products

Stents safe for stroke prevention, study says

Placing a stent to keep a neck artery open is as effective as invasive neck surgery for long-term prevention of strokes, according to results from a European trial.

Honeywell Introduces remote patient monitor

Honeywell Introduces remote patient monitor

Honeywell has launched the HomMed Genesis DM™ v4.15, a new version of the remote patient monitor with new peripheral devices.

NKF launches interactive nutrition portal

NKF launches interactive nutrition portal

The National Kidney Foundation has debuted My Food Coach, an interactive nutrition panel meant to allow people to easily manage nutritional requirements.